Suppr超能文献

支气管肺炎危重症婴儿的疾病负担与治疗实践的变化。

Burden of disease and change in practice in critically ill infants with bronchiolitis.

机构信息

Paediatric Critical Care Research Group, Mater Research Institute, The University of Queensland, Brisbane, Australia

Paediatric Intensive Care Unit, Lady Cilento Children's Hospital, Brisbane, Australia.

出版信息

Eur Respir J. 2017 Jun 1;49(6). doi: 10.1183/13993003.01648-2016. Print 2017 Jun.

Abstract

Bronchiolitis represents the most common cause of non-elective admission to paediatric intensive care units (ICUs).We assessed changes in admission rate, respiratory support, and outcomes of infants <24 months with bronchiolitis admitted to ICU between 2002 and 2014 in Australia and New Zealand.During the study period, bronchiolitis was responsible for 9628 (27.6%) of 34 829 non-elective ICU admissions. The estimated population-based ICU admission rate due to bronchiolitis increased by 11.76 per 100 000 each year (95% CI 8.11-15.41). The proportion of bronchiolitis patients requiring intubation decreased from 36.8% in 2002, to 10.8% in 2014 (adjusted OR 0.35, 95% CI 0.27-0.46), whilst a dramatic increase in high-flow nasal cannula therapy use to 72.6% was observed (p<0.001). We observed considerable variability in practice between units, with six-fold differences in risk-adjusted intubation rates that were not explained by ICU type, size, or major patient factors. Annual direct hospitalisation costs due to severe bronchiolitis increased to over USD30 million in 2014.We observed an increasing healthcare burden due to severe bronchiolitis, with a major change in practice in the management from invasive to non-invasive support that suggests thresholds to admittance of bronchiolitis patients to ICU have changed. Future studies should assess strategies for management of bronchiolitis outside ICUs.

摘要

毛细支气管炎是导致儿科重症监护病房(PICU)非选择性入院的最常见原因。我们评估了澳大利亚和新西兰在 2002 年至 2014 年间 24 个月以下毛细支气管炎患儿入住 ICU 的入院率、呼吸支持和结局的变化。在研究期间,毛细支气管炎导致 34829 例非选择性 ICU 入院的 9628 例(27.6%)。每年毛细支气管炎导致的 ICU 入院率估计增加了 11.76/10 万(95%CI:8.11-15.41)。需要插管的毛细支气管炎患儿比例从 2002 年的 36.8%降至 2014 年的 10.8%(调整后的 OR:0.35,95%CI:0.27-0.46),而高流量鼻导管治疗的使用率则急剧上升至 72.6%(p<0.001)。我们观察到各单位之间的实践存在相当大的差异,风险调整后的插管率差异高达 6 倍,但这并不能用 ICU 类型、规模或主要患者因素来解释。2014 年,因严重毛细支气管炎导致的直接住院费用超过 3000 万美元。我们观察到严重毛细支气管炎的医疗负担不断增加,管理方式从有创支持到无创支持发生了重大变化,这表明毛细支气管炎患儿入住 ICU 的入院标准已经发生了变化。未来的研究应该评估在 ICU 之外管理毛细支气管炎的策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验